Literature DB >> 11316080

Impact of comparison group on cohort dose response regression: an example using risk estimation in atomic-bomb survivors.

J B Cologne1, D L Preston.   

Abstract

Cohort-based dose-response analyses can be biased if based on a comparison group that is not comparable to the exposed persons with respect to uncontrolled factors related to disease incidence or mortality. When data exist over a range of doses including the very low dose region, internal regression standardized analyses based on the regression intercept derived from the exposed subcohort alone can provide risk estimates that are not subject to such comparison-group bias. In the Life Span Study cohort of atomic-bomb survivors, persons with dose estimates of zero comprise a broader geographic distribution than that of persons with non-zero dose estimates. Because there is geographic variation in mortality rates, the zero-dose persons might bias background rate estimates thereby affecting inference about radiation risk. This is illustrated using mortality due to all causes. Restricting the comparison group to certain geographically defined subcohorts resulted in as much as a 6% increase or 8% decrease in the risk estimate. This bias can be corrected using an SMR-type estimate in the regression model, allowing retention of the comparison group in the analysis if it is needed for stability or precision in estimating age, time, and sex effects. Consideration of heterogeneity in comparison groups is particularly important in dose-response studies focused on low doses at which the response may be comparable in magnitude to such heterogeneity.

Entities:  

Mesh:

Year:  2001        PMID: 11316080     DOI: 10.1097/00004032-200105000-00010

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  10 in total

1.  Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.

Authors:  Alina V Brenner; Hiromi Sugiyama; Dale L Preston; Ritsu Sakata; Benjamin French; Atsuko Sadakane; Elizabeth K Cahoon; Mai Utada; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Eur J Epidemiol       Date:  2020-01-25       Impact factor: 8.082

2.  Radiation unlikely to be responsible for high cancer rates among distal Hiroshima A-bomb survivors.

Authors:  Eric J Grant; Yukiko Shimizu; Fumiyoshi Kasagi; Harry M Cullings; Roy E Shore
Journal:  Environ Health Prev Med       Date:  2009-05-02       Impact factor: 3.674

3.  Answer to the comment by Yoshisada Shibata on "Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers".

Authors:  Masaru Miyao; Tomoyuki Watanabe; Ryumon Honda; Yuichi Yamada
Journal:  Environ Health Prev Med       Date:  2009-01-29       Impact factor: 3.674

4.  Selection of reference groups in the Life Span Study of atomic bomb survivors.

Authors:  Benjamin French; John Cologne; Ritsu Sakata; Mai Utada; Dale L Preston
Journal:  Eur J Epidemiol       Date:  2017-12-04       Impact factor: 8.082

5.  Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.

Authors:  John Cologne; Jaeyoung Kim; Hiromi Sugiyama; Benjamin French; Harry M Cullings; Dale L Preston; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Radiat Res       Date:  2019-07-29       Impact factor: 2.841

6.  Use of the individual data of the A-bomb survivors for biologically based cancer models.

Authors:  Wolfgang F Heidenreich; H M Cullings
Journal:  Radiat Environ Biophys       Date:  2009-11-12       Impact factor: 1.925

7.  Population Density in Hiroshima and Nagasaki Before the Bombings in 1945: Its Measurement and Impact on Radiation Risk Estimates in the Life Span Study of Atomic Bomb Survivors.

Authors:  Benjamin French; Sachiyo Funamoto; Hiromi Sugiyama; Ritsu Sakata; John Cologne; Harry M Cullings; Kiyohiko Mabuchi; Dale L Preston
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

8.  Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection.

Authors:  Werner Rühm; Gayle E Woloschak; Roy E Shore; Tamara V Azizova; Bernd Grosche; Ohtsura Niwa; Suminori Akiba; Tetsuya Ono; Keiji Suzuki; Toshiyasu Iwasaki; Nobuhiko Ban; Michiaki Kai; Christopher H Clement; Simon Bouffler; Hideki Toma; Nobuyuki Hamada
Journal:  Radiat Environ Biophys       Date:  2015-09-05       Impact factor: 1.925

9.  Effect of follow-up period on minimal-significant dose in the atomic-bomb survivor studies.

Authors:  John Cologne; Dale L Preston; Eric J Grant; Harry M Cullings; Kotaro Ozasa
Journal:  Radiat Environ Biophys       Date:  2017-11-21       Impact factor: 1.925

10.  Cancer incidence in children and young adults did not increase relative to parental exposure to atomic bombs.

Authors:  S Izumi; K Koyama; M Soda; A Suyama
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.